Authors:
DALEKOS GN
ZERVOU E
ELISAF M
GERMANOS N
GALANAKIS E
BOURANTAS K
SIAMOPOULOS KC
TSIANOS EV
Citation: Gn. Dalekos et al., ANTIBODIES TO HEPATITIS-E VIRUS AMONG SEVERAL POPULATIONS IN GREECE -INCREASED PREVALENCE IN AN HEMODIALYSIS UNIT, Transfusion, 38(6), 1998, pp. 589-595
Citation: K. Bourantas et al., ADMINISTRATION OF HIGH-DOSES OF RECOMBINANT ERYTHROPOIETIN TO PATIENTS WITH BETA-THALASSEMIA-INTERMEDIA - A PRELIMINARY TRIAL (VOL 58, PG 22, 1997), European journal of haematology, 59(1), 1997, pp. 65-65
Citation: K. Bourantas et al., ADMINISTRATION OF HIGH-DOSES OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO PATIENTS WITH BETA-THALASSEMIA-INTERMEDIA - A PRELIMINARY TRIAL, European journal of haematology, 58(1), 1997, pp. 22-25
Authors:
DALEKOS GN
ZERVOU E
ELISAF M
GERMANOS N
BOURANTAS K
GALANAKIS E
SIAMOPOULOS KC
TSIANOS EV
Citation: Gn. Dalekos et al., ANTIBODIES TO HEPATITIS-E VIRUS IN DIFFERENT POPULATIONS IN GREECE - INCREASED PREVALENCE IN AN HEMODIALYSIS UNIT, Hepatology, 26(4), 1997, pp. 1228-1228
Authors:
BOURANTAS K
MAKRYDIMAS G
GEORGIOU I
REPOUSIS P
LOLIS D
Citation: K. Bourantas et al., APLASTIC-ANEMIA - REPORT OF A CASE WITH RECURRENT EPISODES IN CONSECUTIVE PREGNANCIES, Journal of reproductive medicine, 42(10), 1997, pp. 672-674
Authors:
BOURANTAS K
MAKRYDIMAS G
GEORGIOU J
TSIARA S
LOLIS D
Citation: K. Bourantas et al., PRELIMINARY-RESULTS WITH ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN SICKLE CELL BETA-THALASSEMIA PATIENTS DURING PREGNANCY/, European journal of haematology, 56(5), 1996, pp. 326-328
Authors:
BOURANTAS K
TSIARA S
KONSTANTINIDOU P
MITSULISMENTSIKOFF V
CHRISTOU L
Citation: K. Bourantas et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MULTIPLE-MYELOMA, Journal of experimental & clinical cancer research, 15(4), 1996, pp. 371-374
Authors:
BOURANTAS K
MAVRIDIS A
TSIARA S
SEFERIADIS K
Citation: K. Bourantas et al., BETA-2-MICROGLOBULIN IN CHRONIC MYELOGENOUS LEUKEMIA - PRELIMINARY-RESULTS, Journal of experimental & clinical cancer research, 15(3), 1996, pp. 283-286
Authors:
BOURANTAS K
IOACHIM E
DEMOU A
TSIARA S
AGNANTIS NJ
Citation: K. Bourantas et al., PCNA CYCLIN - A DIAGNOSTIC AND PROGNOSTIC FACTOR FOR MYELODYSPLASTIC SYNDROME PATIENTS/, Journal of experimental & clinical cancer research, 15(2), 1996, pp. 191-195
Authors:
MALAMOUMITSI VD
STAVRIDIS C
TSIARA S
BOURANTAS K
Citation: Vd. Malamoumitsi et al., MALIGNANT PLEURAL EFFUSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of experimental & clinical cancer research, 15(2), 1996, pp. 211-213
Citation: K. Bourantas et al., SOLUBLE IL-2 RECEPTORS - A PROGNOSTIC FACTOR FOR MDS PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Journal of experimental & clinical cancer research, 15(1), 1996, pp. 43-47
Authors:
DALEKOS GN
ZERVOU E
BOURANTAS K
TSIANOS EV
Citation: Gn. Dalekos et al., VIRAL HEPATITIDES AND IDIOPATHIC (AUTOIMMUNE) THROMBOCYTOPENIC PURPURA - IS THERE ANY RELATIONSHIP, Journal of hepatology, 25(6), 1996, pp. 1000-1001
Citation: K. Bourantas et al., SUCCESSFUL TREATMENT WITH CORTICOSTEROID IN A PATIENT WITH PROGRESSIVE DIAPHYSEAL DYSPLASIA, Clinical rheumatology, 14(4), 1995, pp. 485-486
Authors:
BOURANTAS K
MITSULISMENTSIKOFF C
TSIARA S
FAKITSA B
GALANAKIS E
CHRISTOU L
NIKIFORAKIS E
Citation: K. Bourantas et al., FOLLOW-UP OF 50 PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL), Journal of experimental & clinical cancer research, 14(3), 1995, pp. 307-312
Authors:
BOURANTAS K
CHRISTOU L
TSIARA S
GALANAKIS E
SIROU M
Citation: K. Bourantas et al., FOLLOW-UP OF 18 PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA, Journal of experimental & clinical cancer research, 14(3), 1995, pp. 321-326
Authors:
BOURANTAS K
CHRISTOU L
TSIARA S
SEFERIADIS K
Citation: K. Bourantas et al., ERYTHROPOIETIN LEVEL IN PATIENTS WITH MYELOPROLIFERATIVE DISEASES, Journal of experimental & clinical cancer research, 14(2), 1995, pp. 175-177
Authors:
BOURANTAS K
CHRISTOU L
TSIARA S
SEFERIADIS K
Citation: K. Bourantas et al., MYELODYSPLASTIC SYNDROMES - ERYTHROPOIETIN LEVEL AND TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, Journal of experimental & clinical cancer research, 14(2), 1995, pp. 205-210
Authors:
BOURANTAS K
BASSIOUKAS K
MALAMOUMITSI VD
HATZIS J
Citation: K. Bourantas et al., PYODERMA-GANGRENOSUM IN 2 PATIENTS WITH MALIGNANT BLOOD-DISEASE, Journal of experimental & clinical cancer research, 14(1), 1995, pp. 79-84
Authors:
VINIOU NA
YATAGANAS X
STAMATOPOULOS K
XEFTERI I
KALMANTIS T
PAPASAVAS P
MITSULIS C
ROMBOS J
MELETIS J
BOURANTAS K
ZOUMBOS N
PANGALIS G
LOUKOPOULOS D
Citation: Na. Viniou et al., REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION FOR THE DIAGNOSIS ANDMOLECULAR MONITORING OF THE PML RAR-ALPHA FUSION GENE IN ACUTE PROMYELOCYTIC LEUKEMIA/, Cancer genetics and cytogenetics, 84(2), 1995, pp. 91-94
Authors:
DALEKOS GN
ZERVOU E
KARABINI F
ELISAF M
BOURANTAS K
SIAMOPOULOS KC
Citation: Gn. Dalekos et al., PREVALENCE OF ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II IN VOLUNTEER BLOOD-DONORS AND HIGH-RISK GROUPS IN NORTHWESTERN GREECE, Transfusion, 35(6), 1995, pp. 503-506
Citation: K. Bourantas et S. Tsiara, REFRACTORY-ANEMIA WITH EXCESS OF BLASTS IN TRANSFORMATION TERMINATINGAS PH NEGATIVE CHRONIC MYELOID-LEUKEMIA, Journal of experimental & clinical cancer research, 13(4), 1994, pp. 415-416